A to Z

FDA

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA Approves Tresiba

FDA Approves Tresiba

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

Issues Related to Healthcare News FDA

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

FDA Backlog Keeps Generics From Coming To Market

FDA Backlog Keeps Generics From Coming To Market

FDA Strengthening Cardiovascular, Stroke Warnings for Rx NSAIDs

FDA Bolsters NSAID Warnings on Heart, Stroke Risk

FDA Commissioner Wants Doctor Education on Opioid Prescribing

FDA Commissioner Wants Doctor Education on Opioid Prescribing

Hangover Treatment Side Effects

FDA Committees Wary of OTC Hangover Remedy

FDA Cracks Down on Online Sellers of Rx Opioids

FDA Cracks Down on Online Sellers of Rx Opioids

man putting in eye drops, eye drop recall

FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations

FDA Drug Recalls and Warnings: Recalls for ADHD Meds and Acne Treatments, doctor looking at computer

FDA Drug Recalls and Warnings: Recalls for ADHD Meds and Acne Treatments, Plus More

FDA Drug Recalls and Warnings: Compounded Semaglutide and Tirzepatide

FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters

drug recalls and warnings, woman looking at pill bottle

FDA Drug Recalls and Warnings: Recalls For Generic Duloxetine, Levothyroxine, Gabapentin & More

FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops

FDA Drug Interactions/Side Effects

FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops

FDA Encouraging Industry to Make More Opioid Abuse Therapies

FDA Encouraging Industry to Make More Opioid Abuse Therapies

FDA Finds Eye Injections Caused Vision Impairment

FDA Finds Eye Injections Caused Vision Impairment

Issues Related to Healthcare News FDA

FDA Finds High Levels of Heavy Metals in Kratom Samples

FDA Flip-Flops on Safety of Testosterone Replacement Therapy

FDA Flip-Flops on Safety of Testosterone Replacement Therapy

FDA Gives Singulair the Thumbs Down for OTC

FDA Gives Singulair the Thumbs Down for OTC

skin sensitive to the sun

FDA Goes After Companies Marketing Sun Protection Supplements

FDA Issues Heart Warning for Antibiotic

FDA Issues Heart Warning for Antibiotic

Load More

x

x